Cameron Turtle, CBO at Eidos Therapeutics, holds 746.91K shares in Spyre Therapeutics (Ticker: SYRE), holds 12.57K shares in BridgeBio Pharma (Ticker: BBIO), holds 50.62K shares in Eidos Therapeutics (Ticker: EIDX).

See the Hottest Stocks Based on Insider Trading >

Cameron Turtle
Eidos Therapeutics (EIDX)
CBO

Ranked #93,909 out of 99,024 Corporate Insiders

Profitable Transactions

1 out of 5 Profitable Transactions

Average Return

-61.20%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

98.68%

SYRE

1.32%

BBIO

A breakdown of Cameron Turtle's holdings

See the Top Stocks by Insiders

Insider Roles

Spyre Therapeutics
(SYRE)

CEO, Director

BridgeBio Pharma
(BBIO)

SVP, Portfolio Management and Corporate Developmen

Roles that Cameron Turtle holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Eidos Therapeutics
(EIDX)

Rating:Informative Sell

Date:Sep 06, 2019 - Sep 06, 2020

Return:+2.10%

The most profitable trade made by Cameron Turtle

See the Latest Stocks Traded by Insiders

Cameron Turtle's Trading History

EIDX

Eidos Therapeutics

Dec 16, 2020

―

Informative Sell

2.94M

$6.19M

BBIO

BridgeBio Pharma

Dec 29, 2020

SVP, Portfolio Management and Corporate Developmen

Uninformative Sell

1.36M

$378.17K

SYRE

Spyre Therapeutics

Feb 20, 2024

CEO, Director

Uninformative Buy

3.93K

$28.23M

List of latest transactions for each holding click on a transaction to see Cameron Turtle's performance on stock

See All Insider Trading from Today

Cameron Turtle insider profile FAQ

What is the percentage of profitable transactions made by Cameron Turtle?

The percentage of profitable transactions made by Cameron Turtle is 20%.

What is the average return per transaction made by Cameron Turtle?

The average return per transaction made by Cameron Turtle is -61.20%.

What stocks does Cameron Turtle hold?

Cameron Turtle holds: EIDX, BBIO, SYRE stocks.

What was Cameron Turtle’s latest transaction?

Cameron Turtle latest transaction was an Uninformative Buy of $3.93K.

What was Cameron Turtle's most profitable transaction?

Cameron Turtle’s most profitable transaction was an Informative Sell of EIDX stock on September 6, 2019. The return on the trade was 2.10%.

What is Cameron Turtle's role in Eidos Therapeutics?

Cameron Turtle's role in Eidos Therapeutics is CBO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Cameron Turtle Insider Profile

Cameron Turtle Eidos Therapeutics (EIDX)CBO